A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat.

scientific article

A novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000228915
P698PubMed publication ID19609089

P50authorMarina A LynchQ41528054
P2093author name stringMichelle Walsh
Anne-Marie Miller
Helen E Skerrett
Patricia Byrne
Arkady Mandel
Darren S D Martin
Anthony E Bolton
P433issue6
P921main subjectmicrogliaQ1622829
P304page(s)400-410
P577publication date2009-07-17
P1433published inNeuroimmunomodulationQ15756353
P1476titleA novel phospholipid-based drug formulation, VP025, modulates age- and LPS-induced microglial activity in the rat.
P478volume16

Reverse relations

cites work (P2860)
Q41537684Are inflammatory profiles the key to personalized Alzheimer's treatment?
Q91604209CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease
Q27014919Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy
Q35651667Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes

Search more.